• Consequences of giving birth to women carriers of antibodies to thyroid peroxidase
en To content Full text of article

Consequences of giving birth to women carriers of antibodies to thyroid peroxidase

Ukrainian Journal of Perinatology and Pediatrics. 2024. 1(97): 45-49. doi: 10.15574/PP.2024.97.45
Tsmur O. V., Getsko N. V.
SHEI «Uzhgorod National University», Ukraine

For citation: Tsmur OV, Getsko NV. (2024). Consequences of giving birth to women carriers of antibodies to thyroid peroxidase. Ukrainian Journal of Perinatology and Pediatrics. 1(97): 45-49. doi: 10.15574/PP.2024.97.45.
Article received: Oct 10, 2023. Accepted for publication: Mar 12, 2024.

Aim of the research to analyze obstetric and perinatal complications of pregnancy and childbirth, the condition of newborn babies, pregnant women carriers of antibodies to thyroid peroxidase (TPOAb) in order to improve the effectiveness of their diagnosis and prevention.
Materials and methods. A retrospective study was conducted of 140 histories of pregnancy and childbirth of women carriers of TPOAb, as well as the histories of their newborns – the main group (MG).The criteria for inclusion in the main group was the presence of an TPOAb titer higher than 100 IU/ml. The comparison group (CG) consisted of 40 birth histories of women without an elevated level of TPOAb, somatic pathology and with a physiological course of the gestational period, as well as 40 histories of their newborns. Statistical processing of research results was carried out using standard Microsoft Excel 5.0 and Statistica 6.0 programs.
Results. It was established that female patients carrying TPOAb have a higher percentage of the following gestational complications: threats of termination of pregnancy (pregnancy in MG was terminated in 6 cases: frozen pregnancy in 2 (1.4%) cases, spontaneous abortion in the I trimester – 3 (2.1%) cases, spontaneous abortion in the II trimester – 1 (0.7%) case; threats of premature birth – 13 (9.3%) cases; fetal growth restriction syndrome – 8 (5.7%) cases; preeclampsia 22 (15.7%) cases against 2 (5.0%), p<0.001. Premature birth was observed only in MG patients and accounted for 24 (17.9%) cases. The rate of pathological labor was significantly different in the research groups. A high specific weight of pathological births childbirth was observed in women carriers of TPOAb – 47 (35.1%) cases in CG versus 4 (10.0%) cases in CG, p<0.05. Cesarean section was performed in 38 (27.1%) patients MG and 3 (7.5%) pregnant women CG.
Conclusions. In the course of the retrospective study, it was revealed that women carriers of TPOAb have a higher percentage of the development of such gestational and perinatal complications as the threat of abortion and miscarriage, fetal distress, preeclampsia of various degrees of severity, pathological childbirth and asphyxia of newborns compared to patients with normal level of TPOAb.
The research was conducted according to principles of the Declaration of Helsinki. The study protocol was approved by the Local Ethics Committee of the institution indicated in the work.The informed consent of women was obtained for conducting the study.
No conflict of interests was declared by the authors.
Keywords: pregnancy, thyroid function, antibodies to thyroid peroxidase, course of pregnancy, childbirth, condition of newborns.

 

REFERENСЕS

1. Ahtamovna ZZ. (2022). Secondary infertility in women of reproductive age with hypothyroidism. ACADEMICIA: An International Multidisciplinary Research Journal. 12(5): 649-653. https://doi.org/10.5958/2249-7137.2022.00424.4

2. Ajmani NS, Sarbhai V, Yadav N, Paul M, Ahmad A, Ajmani AK. (2016, Apr). Role of Thyroid Dysfunction in Patients with Menstrual Disorders in Tertiary Care Center of Walled City of Delhi. J Obstet Gynaecol India. 66(2): 115-119. Epub 2015 Jan 20. https://doi.org/10.1007/s13224-014-0650-0; PMid:27046965 PMCid:PMC4818825

3. Akande AA, Isah IA, Aliyu IS, Adesiyun AG. (2022, Jun). Thyroid dysfunction in women of reproductive age: laboratory protocol for infertility evaluation. Ann Ib Postgrad Med. 20(1): 53-57. PMID: 37006645; PMCID: PMC10061663.

4. Aljarad M, Alhalabi N, Hamad A, Nmr N, Abbas F, Alkhatib A et al. (2019, Aug 3). Prevalence of Thyroid Autoimmune Antibodies in Women Seeking Fertility Care in Damascus, Syria. Cureus. 11(8): e5315. https://doi.org/10.7759/cureus.5315; PMid:31592370 PMCid:PMC6773447

5. Chaudhary A, Bhatia BK. (2021). Relationship between thyroid disorder and abnormal menstrual bleeding. Int. J. Cur. Res. Rev. 13 (02): 29-32. https://doi.org/10.31782/IJCRR.2021.13216

6. Fan J, Zhang Y, Zhang C, Barjaktarovic M, Yang X, Peeters RP et al. (2019). Persistency of thyroid dysfunction from early to late pregnancy. Thyroid. 29(10): 1475-1484. https://doi.org/10.1089/thy.2019.0115; PMid:31347461

7. Jenishia M. (2020). Thyroid Disorders during Pregnancy. International Journal of Nursing Education and Research. 8(3): 391-393. https://doi.org/10.5958/2454-2660.2020.00084.8

8. Kahaly GJ. (2020, Dec 1). Management of Graves Thyroidal and Extrathyroidal Disease: An Update. J Clin Endocrinol Metab. 105(12): 3704-3720. https://doi.org/10.1210/clinem/dgaa646; PMid:32929476 PMCid:PMC7543578

9. Kahaly GJ, Bartalena L, Hegedüs L, Leenhardt L, Poppe K, Pearce SH. (2018, Aug). European Thyroid Association Guideline for the Management of Graves' Hyperthyroidism. Eur Thyroid J. 7(4): 167-186. Epub 2018 Jul 25. https://doi.org/10.1159/000490384; PMid:30283735 PMCid:PMC6140607

10. Kiran Z, Sheikh A, Malik S, Meraj A, Masood M, Ismail S et al. (2019). Maternal characteristics and outcomes affected by hypothyroidism during pregnancy (maternal hypothyroidism on pregnancy outcomes, MHPO-1). BMC pregnancy and childbirth. 19(1): 1-12. https://doi.org/10.1186/s12884-019-2596-9; PMid:31805890 PMCid:PMC6896307

11. Knøsgaard L et al. (2020). Thyroid function abnormalities and thyroid autoantibodies in Danish pregnant women. Clinical Endocrinology. 93(3): 329-338. https://doi.org/10.1111/cen.14147; PMid:31876038

12. Kundoor R, Rani BS. (2019). Thyroid function in abnormal uterine bleeding. Int. J. Reprod. Contracept. Obstet. and Gynecol. 8 (6): 2270-2274. https://doi.org/10.18203/2320-1770.ijrcog20192416

13. Lee SY, Pearce EN. (2021). Testing, monitoring, and treatment of thyroid dysfunction in pregnancy. The Journal of Clinical Endocrinology & Metabolism. 106(3): 883-892. https://doi.org/10.1210/clinem/dgaa945; PMid:33349844 PMCid:PMC7947825

14. Li N, Yang J, Chen X, Huang J, Lai M, Fang F et al. (2020). Postpartum follow-up of patients with subclinical hypothyroidism during pregnancy. Thyroid. 30(11): 1566-1573. https://doi.org/10.1089/thy.2019.0714; PMid:32375594

15. Mintser AP. (2018). Statisticheskie metodyi issledovaniya v klinicheskoy meditsine. Prakticheskaya meditsina. 3: 41-45.

16. Romanenko TG, Chayka O. (2017). Features of menstrual function in women with infertility and thyroid gland pathology. Health of woman. 6(122): 40-44. https://doi.org/10.15574/HW.2017.122.40

17. Silva JF, Ocarino NM, Serakides R. (2018). Thyroid hormones and female reproduction. Biol. Reprod. 99 (5): 907-921. https://doi.org/10.1093/biolre/ioy115; PMid:29767691

18. Van Trotsenburg ASP. (2020, Jul). Management of neonates born to mothers with thyroid dysfunction, and points for attention during pregnancy. Best Pract Res Clin Endocrinol Metab. 34(4): 101437. Epub 2020 Jun 18. https://doi.org/10.1016/j.beem.2020.101437; PMid:32651060

19. Verma A, Kaur AP, Shergill HK, Kaur S. (2017). Menstrual disorders in thyroid dysfunction. Eur. J. of Bio- medical. 4 (2): 197-201.

20. Wang J, Gong XH, Peng T, Wu JN. (2021). Association of thyroid function during pregnancy with the risk of pre-eclampsia and gestational diabetes mellitus. Endocrine Practice. 27(8): 819-825. https://doi.org/10.1016/j.eprac.2021.03.014; PMid:33831553

21. Wang Y, Zhou R, Wang J. (2019). Relationship between hypothyroidism and endometrial cancer. Aging Dis. 10 (1): 190-196. https://doi.org/10.14336/AD.2018.0224; PMid:30705778 PMCid:PMC6345335

22. Xie J et al. (2020). Effect of antithyroid antibodies on women with recurrent miscarriage: A meta-analysis.Am. J. Reprod. Immunol. 83 (6): e13238. https://doi.org/10.1111/aji.13238; PMid:32198952 PMCid:PMC7317526

23. Yuzko OM. (2018). Porushennia funktsiï shchytopodibnoï zalozy v zhinok iz bezpliddiam ta anomalnymy matkovymy krovotechamy. Klinichna ta eksperymentalna medytsyna. 17; 3 (65): 109-112. doi: 10.24061/1727-4338.XVII.3.65.2018.142

24. Zhang Y, Li Y, Shan Z, Xu Y, Li C, Xie X et al. (2019). Association of overt and subclinical hyperthyroidism during weeks 4-8 with adverse pregnancy outcomes. Journal of Women's Health. 28(6): 842-848. https://doi.org/10.1089/jwh.2018.7180; PMid:30855205